Economy

10-year Treasury yield posts huge leap to 4.47% on Trump win, possible GOP Congress sweep

Trump Victory Sends Treasury Yields Surging A specialist trader works inside a post on the floor at the New York Stock Exchange on Oct. 23, 2024. Brendan McDermid | Reuters

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Economy

Nvidia’s AI Dominance Is Still Building. Could the Stock Go Even Higher?

Nvidia, a dominant player in the artificial intelligence (AI) industry, has seen tremendous growth in recent years. With a compound

What to Know Before Buying The Metals Company Stock

When it comes to envisioning a mining company, the typical image that comes to mind is one of giant yellow

Wells Fargo Stock Just Hit an All-Time High. Here Are 2 Tailwinds Behind the Banking Giant.

Wells Fargo has come a long way from its tumultuous past. Just a few years ago, the bank was mired

Here’s How MercadoLibre Gets to $3,000 Per Share in 2026

MercadoLibre (NASDAQ: MELI) has faced challenges in 2025 despite its strong position in Latin America's e-commerce and fintech sectors. Currently

3 Takeaways Investors Should Know Before Entering 2026

The Trade Desk: Navigating a Changing Landscape in 2026 As we approach the end of 2025, The Trade Desk (NASDAQ:

Dell increasing prices on surging demand for memory units, Business Insider says

Starting December 17, Dell Technologies (DELL) will be implementing price increases across its commercial product lines. This decision was communicated

1 Magnificent S&P 500 Dividend Stock Down 27% to Buy and Hold Forever

General Mills, a staple in the consumer-packaged goods sector, has not been immune to the recent weaknesses affecting the industry.

ImmunityBio (IBRX) Climbs 7.76% on Europe Expansion

ImmunityBio Inc. (NASDAQ:IBRX) made headlines recently with a significant jump in stock price following the approval of its bladder cancer